DENVER– Cleerly, a company focused on cardiovascular imaging, has promoted two senior leaders into expanded roles. Dr. Udo Hoffmann has been named Chief Medical, Scientific and AI Officer, while Amit Relia has been promoted to Chief Regulatory Officer.
Hoffmann, who joined Cleerly in 2022, will now oversee several departments including scientific and medical affairs, AI and data science, and regulatory and quality. Before joining the company, he was a professor at Harvard Medical School and led cardiovascular imaging at Massachusetts General Hospital. His academic work includes leading several federally funded clinical trials and publishing extensively in major medical journals.
Relia, who joined Cleerly in 2024, will now lead the company’s regulatory efforts. He previously worked at iRhythm Technologies, Apple Health, and Intuitive, where he focused on regulatory approvals for medical devices and software, including AI-based technologies.
The leadership changes come as Cleerly continues to grow and bring its products to more markets.
